These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3580568)

  • 1. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy.
    Miletich JP; Broze GJ
    Blood; 1987 Jun; 69(6):1580-6. PubMed ID: 3580568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of normal and abnormal prothrombin and protein C in plasma using a calcium ion-inhibited monoclonal antibody to a common epitope on several vitamin K-dependent proteins.
    Church WR; Bhushan FH; Mann KG; Bovill EG
    Blood; 1989 Nov; 74(7):2418-25. PubMed ID: 2804372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal-antibody-based radioimmunoassay for measurement of protein C in plasma.
    Howard PR; Bovill EG; Mann KG; Tracy RP
    Clin Chem; 1988 Feb; 34(2):324-30. PubMed ID: 3124980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient, vitamin K-dependent and warfarin-sensitive secretion.
    Souri M; Iwata H; Zhang WG; Ichinose A
    Blood; 2009 Apr; 113(16):3857-64. PubMed ID: 19188667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acquired vitamin K-dependent gamma-carboxylation deficiency in hepatocellular carcinoma involves not only prothrombin, but also protein C.
    Yoshikawa Y; Sakata Y; Toda G; Oka H
    Hepatology; 1988; 8(3):524-30. PubMed ID: 2836289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Protein Z.
    Broze GJ; Miletich JP
    J Clin Invest; 1984 Apr; 73(4):933-8. PubMed ID: 6707212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of human protein S in the plasma of normal and warfarin-treated individuals by radioimmunoassay.
    Fair DS; Revak DJ
    Thromb Res; 1984 Dec; 36(6):527-35. PubMed ID: 6241357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states.
    Rapaport SI; Zivelin A; Donnelly K
    Am J Clin Pathol; 1987 Apr; 87(4):491-7. PubMed ID: 3826014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-hydroxyaspartic acid in vitamin K-dependent plasma proteins from scorbutic and warfarin-treated guinea pigs.
    Stenflo J; Fernlund P
    FEBS Lett; 1984 Mar; 168(2):287-92. PubMed ID: 6723952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.
    Weiss P; Soff GA; Halkin H; Seligsohn U
    Thromb Res; 1987 Mar; 45(6):783-90. PubMed ID: 2954263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII lability, protein C and other vitamin K-dependent proteins.
    Takahashi H; Hanano M; Tatewaki W; Shibata A
    Thromb Res; 1986 Sep; 43(5):561-8. PubMed ID: 3092397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.
    Mikami S; O'Brien DP; Mellars G; Goodall AH; Tuddenham EG
    Br J Haematol; 1986 Mar; 62(3):513-24. PubMed ID: 3485443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein S activity measured using Protac, a snake venom derived activator of protein C.
    Suzuki K; Nishioka J
    Thromb Res; 1988 Jan; 49(2):241-51. PubMed ID: 2966451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.
    Takahashi H; Hanano M; Hayashi S; Arai Y; Yoshino N; Takakuwa E; Tatewaki W; Nagayama R; Takizawa S; Shibata A
    Tohoku J Exp Med; 1986 Aug; 149(4):351-7. PubMed ID: 3775760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion, gamma-carboxylation, and endoplasmic reticulum-associated degradation of chimeras with mutually exchanged Gla domain between human protein C and prothrombin.
    Tokunaga F; Takeuchi S; Omura S; Arvan P; Koide T
    Thromb Res; 2000 Sep; 99(5):511-21. PubMed ID: 10973682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements.
    Lubetsky A; Seligsohn U; Ezra D; Halkin H
    Clin Pharmacol Ther; 1992 Jul; 52(1):42-9. PubMed ID: 1385564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM; Thom JY; Ivey JG; Baker RI
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy.
    Furie B; Liebman HA; Blanchard RA; Coleman MS; Kruger SF; Furie BC
    Blood; 1984 Aug; 64(2):445-51. PubMed ID: 6743826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.